Immunotherapy, a rapidly evolving field in medicine, has revolutionized cancer treatment by leveraging the body's immune system to fight disease. This guide aims to provide an overview of the fundamental aspects of immunotherapy, enabling physicians to better understand and apply this treatment modality in clinical practice.
Immunotherapy works on the principle of enhancing the immune system's ability to detect and destroy cancer cells. It involves the use of treatments that stimulate immune responses or counteract mechanisms that cancer cells use to evade the immune system. There are several types of immunotherapies including immune checkpoint inhibitors, cancer vaccines, and adoptive cell therapies.
Immune checkpoint inhibitors are drugs that block immune checkpoints - proteins that prevent immune cells from attacking non-harmful cells in the body. Some cancer cells exploit these checkpoints to avoid being targeted by the immune system. By blocking these checkpoints, these inhibitors enable the immune system to recognize and attack cancer cells.
Cancer vaccines, unlike traditional vaccines, are usually given after a cancer diagnosis to stimulate the immune system to attack cancer cells. They can be made from a variety of materials, including cells, proteins, or DNA, and can be patient-specific or off-the-shelf.
Adoptive cell therapies involve the use of T-cells, a type of white blood cell, to fight cancer. In some therapies, T-cells are removed from a patient, genetically modified to recognize specific cancer cells, and then infused back into the patient.
Immunotherapy represents a significant advancement in cancer treatment, offering new hope to patients with various types of malignancies. As research continues to evolve, it's crucial for physicians to stay informed about these developments to provide the best possible care for their patients. Understanding the fundamentals of immunotherapy is the first step in this important journey.
1.
Trial Supports Ivonescimab and Chemo for NSCLC Survival
2.
Cancer "Tidal Wave" Prediction: Not Cigarette-Based, Either! Wary Stories Regarding Cannabis and Cancer.
3.
Lymph node transfer reduces arm swelling after breast cancer surgery, study shows
4.
Silibinin is a novel and ancient molecule that highlights the significance of integrated therapies for cancer.
5.
Research Indicates that First-Line Immunotherapy Is Enough for Elderly NSCLC Patients?
1.
Unlocking the Power of Hematocrit: Exploring the Benefits of Blood Cell Counts
2.
Unpacking Chordoma: Understanding the Rare Cancer and its Treatment Options
3.
Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025
4.
Uncovering the Mysteries of the RDW Blood Test
5.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part II
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
3.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
4.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
5.
Navigating the Complexities of Ph Negative ALL - Part XIV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation